Litecoin arises at a maximum of 5 months when pharmacist buys USD $ 100 million LTC
Mei Pharma became the first public company in the United States to adopt Litecoin as a treasury reserve asset. Its purchase promoted the price of LTC more than 3% to USD $ 122.
***
- Mei Pharma bought more than 900,000 LTC for its corporate portfolio, promoting prices.
- It is the first public company in the USA in building a treasury strategy centered on Litecoin.
- The price of LTC shot February maximums over USD $ 127.
- The hopes of approval of an ETF Litecoin also feed the upward narrative.
The price of Litecoin (LTC) is now shooting that a company chooses the cryptocurrency for its treasury.
Mei Pharmaa pharmaceutical company that lies in Nasdaq, revealed on Tuesday that it has acquired tokens LTC for an approximate value of USD $ 100 million, thus becoming the First company that quotes in the United States market to adopt Litecoin as its main treasury reserve asset.
In a regulatory presentation, the company detailed has acquired 929,548 LTC at an average USD price $ 107.58. Purchases were made between July 30 and August 4, according to the paperwork of the Bag and Securities Commission (SEC).
The news seemed to help boost the price of LTC to a maximum of five months. The graphics Coingcko show that Litecoin It emerged momentarily above USD $ 128 on Tuesday, taking up a price level seen for the last time at the end of February.

At current market prices of around $ 124 per Token, holdings of Litecoin of the newly released treasury of Mei Pharma They would be valued at USD $ 114 million, depending on the calculations.
The first Litecoin Treasury in the US.
Mei Pharmawhich focuses on the development of innovative therapies for cancer treatment, had announced a private placement for 100 million dollars last month, with the creator of LitecoinCharlie Lee, and the cryptocurrency company GSR acting as main investors.
Lee has joined the Board of Directors of Mei and GSR has been appointed Treasury Asset Administrator of the Company. Other investors included Litecoin Foundation, Parafi, Hivemind, Primitive, RLH Capital and Delta Blockchainhe reported The Block.
The pharmacist had cited in a statement the history of more than a decade of Litecoinas well as its low rates and rapid settlement, such as some of the reasons for your choice as treasury assets. He also mentioned the integration of Litecoin on platforms such as Bitpay, PayPal and Robinhood as signs that validate their usefulness.
“This initiative represents the first time that a public company aligns its treasury strategy with Litecoin at the institutional level“Said Joshua Riezman, GSR strategy director in the United States. “It reflects a growing institutional confidence in credibility, resilience and regulatory clarity of LTC”
The model of Mei Pharma It is distinguished from the more than 160 public companies worldwide that have chosen to buy Bitcoin For their corporate wallets, replicating the strategy of Strategy from Michael Saylor. Other entities have also rushed to build treasury Altcoins as Ethereum, Solana and XRP in the middle of a broader trend of corporate adoption.
Mei He has advanced that he could expand his strategy to include mining Litecoin and other initiatives, as it continues to operate its line of development of experimental drugs, according to coverage.
Hopes of an ETF also drive LTC
Created in 2011, Litecoin It is a decentralized open -source cryptoc Bitcoin. It is currently one of the most established digital currencies, with a market capitalization of USD $ millions, which positions it in the number 24 between the larger cryptocurrencies.
In addition to the corporate support of a public company, LTC could also be benefiting from the perspective of approval of an upcoming fund quoted in the stock market (ETF) of Litecoin in cash in the US market.
The administrators Coinshares, Grayscale and Canary Capital They have requested the SEC to approve the launch of ETF with direct exposure to Litecoin Amid a broader interest in investors to access Cryptocurrency ETF. Although the regulator has not yet given an answer, the regulatory change of the Trump administration has fed the hopes of an approval. In PolymarketUsers show a probability of 80% approval this year.
LTC is negotiated 3.7% higher in 24 hours, at a price of USD $ 123 at the time of writing these lines. The Altcoin It accumulates a gain of almost 14% in the week and more than 100% in the year, according to data.
Hannah Estefanía Pérez / Diariobitcoin
Image generated with AI tool, under free use license
WARNING: Diariobitcoin offers informative and educational content on various topics, including cryptocurrencies, AI, technology and regulations. We do not provide financial advice. Cryptactive investments are high risk and may not be adequate for all. Investigate, consult an expert and verify the applicable legislation before investing. I could lose all its capital.
Subscribe to our newsletter
